Status:
NOT_YET_RECRUITING
Research of the Application of Artificial Intelligence Model "PANDA"
Lead Sponsor:
Zhejiang University
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
The research objective of this project is to conduct a large-scale and prospective real-world validation of the Pancreatic Cancer Screening Model PANDA, which was developed based on deep learning and ...
Detailed Description
This study focuses on potential cases of clinically missed PDAC. It aims to evaluate the pancreatic cancer screening model PANDA, based on deep learning and non-enhanced CT scans, in a prospective rea...
Eligibility Criteria
Inclusion
- The participants have undergone chest and/or abdominal plain CT scans at outpatient, inpatient, or physical examination centers
Exclusion
- Chest CT scan without pancreatic coverage
- Patients undergoing thoracic/abdominal surgical procedures that affect or alter the anatomical display of the pancreas (esophageal/gastric/pancreatic/vascular/ERCP postoperative, etc.)
- Scanning non-standard examinations, such as significant respiratory motion artifacts
Key Trial Info
Start Date :
August 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
200000 Patients enrolled
Trial Details
Trial ID
NCT06528223
Start Date
August 15 2024
End Date
December 31 2027
Last Update
July 30 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
the First Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China, 310003
2
the First Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China, 310009